Upregulation of p21Cip1 in activated glial cells
Upregulation of p21Cip1 in activated glial cells
复制标题
DOI:
10.1002/glia.20781
复制
发表时间:
2009-04
期刊:
影响因子:
6.2
通讯作者:
J. Tusell;Aroa Ejarque‐Ortíz;P. Mancera;C. Solà;J. Saura;J. Serratosa
中科院分区:
文献类型:
--
作者:
J. Tusell;Aroa Ejarque‐Ortíz;P. Mancera;C. Solà;J. Saura;J. Serratosa
The cdk inhibitor p21Cip1, also named p21Cip1/Waf1, is intimately involved in coupling growth arrest to cellular differentiation in several cell types. p21Cip1 is a multifunctional protein that might regulate cell‐cycle progression at different levels. In a recent study, we found no differences in the rate of proliferation between glial cells from wild‐type and p21Cip1−/− mice. In the present study, we examined differences in glial activation between glial cells from wild‐type and p21Cip1−/− mice, using mixed glial cultures, microglia‐enriched cultures, and astrocyte‐enriched cultures. We compared the effect of lipopolysaccharide and two forms (oligomeric and fibrillar) of the 1‐42 β‐amyloid peptide on glial activation. We observed an attenuation of nuclear translocation of the nuclear factor kappa‐B in p21Cip1−/− glial cells, when compared with glial cells from wild‐type mice. In contrast, tumor necrosis factor‐α release was enhanced in p21Cip1−/−microglial cells. In addition glial activation induced by lipopolysaccharide and the fibrillar form of the 1‐42 β‐amyloid peptide upregulated p21Cip1. Our results support a role for p21Cip1 in the activation of glial cells, particularly in microglia. © 2008 Wiley‐Liss, Inc.